Derek T. Hall
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
pADP-ribosylation regulates the cytoplasmic localization, cleavage, and pro-apoptotic function of HuR.
Journal: Life science alliance
Published: August 13, 2023
Tankyrase-1 regulates RBP-mediated mRNA turnover to promote muscle fiber formation.
Journal: Nucleic acids research
Published: December 15, 2022
Pharmacological or genetic inhibition of iNOS prevents cachexia-mediated muscle wasting and its associated metabolism defects.
Journal: EMBO molecular medicine
Published: October 14, 2020
GLI3 regulates muscle stem cell entry into GAlert and self-renewal.
Journal: Nature communications
Published: April 22, 2020
Depletion of HuR in murine skeletal muscle enhances exercise endurance and prevents cancer-induced muscle atrophy.
Journal: Nature communications
Published: October 23, 2018
Alternative polyadenylation and the stress response.
Journal: Wiley interdisciplinary reviews. RNA
Published: June 27, 2018
The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting.
Journal: EMBO molecular medicine
Published: May 31, 2018
STAT3 promotes IFNγ/TNFα-induced muscle wasting in an NF-κB-dependent and IL-6-independent manner.
Journal: EMBO molecular medicine
Published: March 08, 2017
The impact of mRNA turnover and translation on age-related muscle loss.
Journal: Ageing research reviews
Published: March 12, 2012
The translation inhibitor pateamine A prevents cachexia-induced muscle wasting in mice.
Journal: Nature communications
Published: November 04, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026